DETAILED ACTION
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status.
Continued Examination Under 37 CFR 1.114
A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 02/04/26 has been entered.
Response to Amendment
The rejection of Claims 3-6 under 35 U.S.C. 103 as being unpatentable over Kim et al. (US 2016/0155976 A1) in view of Yoon et al. (WO 2020/050624 A1) as set forth in the Final Rejection filed 11/06/25 is overcome by the cancellation of the claims.
The rejection of Claims 1 and 8-33 under 35 U.S.C. 103 as being unpatentable over Kim et al. (US 2016/0155976 A1) in view of Yoon et al. (WO 2020/050624 A1) as set forth in the Final Rejection filed 11/06/25 is overcome by the Applicant’s amendments.
Specification
The disclosure is objected to because of the following informalities: The Specification filed 04/22/21 recites chemical structures on pages 23-27, 53-55, and 57 which are all graphically unclear due to their low resolution and small size. They all need to be replaced by structures which are clearly legible, with all bonds and atoms that are clearly drawn (with solid lines).
Appropriate correction is required.
Claim Objections
7. Claims 1 and 8-33 are objected to because of the following informalities:
Claim 1, which the other claims are dependent upon, recites the structures of EH-58, EH-59, and EH-60 (page 7) which are all graphically unclear due to their low resolution. They need to be replaced by structures comprising bonds, atoms, and labels which are clearly drawn (with solid lines).
Appropriate correction is required.
Claim Rejections - 35 USC § 112
8. The following is a quotation of 35 U.S.C. 112(b):
(b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention.
The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph:
The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention.
9. Claim 14 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention.
The claim, which is dependent on Claim 1, recites “L comprises unsubstituted or substituted phenylene” which renders the exact scope of the claim definite as “L” lacks antecedent basis.
Correction is required.
Allowable Subject Matter
10. Claims 1, 8-13, and 15-33 are currently objected to due to minor informalities, but would be allowable if rewritten to overcome the objection as set forth above.
The closest prior art is provided by Yoon et al. (WO 2020/050624 A1), which discloses compounds of the following form for use in the light-emitting layer of an organic electroluminescent (EL) device (organic light emitting diode) ([0237]-[0238]):
PNG
media_image1.png
244
312
media_image1.png
Greyscale
([46]). An embodiment is disclosed:
PNG
media_image2.png
136
136
media_image2.png
Greyscale
(page 67). However, it is the position of the Office that neither Yoon et al. singly nor in further combination with any other prior art discloses any of the organic compounds as recited in Claim 1, particularly in regards to the specific nature of the substituent groups attached to the triazine.
Response to Arguments
11. Applicant’s arguments on pages 1-3 have been fully considered and are persuasive. The 35 U.S.C. 103 rejection as set forth in the previous Office Action has been withdrawn.
Conclusion
12. Any inquiry concerning this communication or earlier communications from the examiner should be directed to JAY L YANG whose telephone number is (571)270-1137. The examiner can normally be reached Mon-Fri, 6am-3pm.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer A Boyd can be reached at 571-272-7783. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/JAY YANG/Primary Examiner, Art Unit 1786
Prosecution Insights